CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Cash flows from operating activities:
Net income	$ 30,944	$ 20,409
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	21,319	20,209
Share-based compensation	3,021	3,392
Amortization of deferred debt issuance costs	440	440
Income tax (benefit) expense	1,105	(176)
Provision for doubtful accounts	4,616	2,528
Inventory write-downs	3,143	1,191
Excess tax benefit of stock option exercises	(1,406)	(341)
Other	(85)	487
Change in operating assets and liabilities:
Accounts and notes receivable	(2,610)	8,525
Inventories	(17,387)	(31,443)
Prepaid and refundable income tax and income tax payable	2,947	21,488
Other current assets and other assets	(8)	(4,992)
Accounts payable	(7,880)	(3,937)
Accrued liabilities and jackpot liabilities	(4,779)	2,082
Deferred revenue and deferred cost of revenue	4,342	6,431
Net cash provided by operating activities	37,722	46,293
Cash flows from investing activities:
Acquisition		(6,000)
Capital expenditures	(4,220)	(1,634)
Restricted cash and investments	2,102	(786)
Additions to other long-term assets	(347)	(1,581)
Net cash used in investing activities	(2,465)	(10,001)
Cash flows from financing activities:
Proceeds from revolving credit facility	50,000
Payments on revolving credit facility		(5,000)
Payments on long-term debt and capital leases	(3,757)	(3,760)
Distributions to noncontrolling interests		(37)
Purchase of treasury stock	(68,076)	(31,306)
Excess tax benefit of stock option exercises	1,406	341
Proceeds from exercise of stock options and employee stock purchases	7,445	2,006
Net cash used in financing activities	(12,982)	(37,756)
Effect of exchange rate changes on cash	863	(3,024)
Cash and cash equivalents:
Increase (decrease) for period	23,138	(4,488)
Balance, beginning of period	32,673	66,425
Balance, end of period	$ 55,811	$ 61,937